"Future Health" thought leader launches MUST watch playlist

Ira Pastor is ideaXme longevity and aging ambassador and founder of Bioquark Inc. a life sciences company, developing proprietary combinatorial biologics for the regeneration and repair of human organs and tissues. His work within the field on longevity and aging has been featured across the world's media.

On 7 February 2019, Pastor launched his ideaXme playlist.

In just 5 weeks, he has interviewed 9 of the world's leading figures within the fields of longevity and aging science including specifically, pain control, bioengineering, quantum biology, oncology, biomedical gerontology and molecular genetics.

Those people are:

Peter A McNaughton, Professor Pharmacology Kings College, London.

McNaughton is a senior scientist heading a group which aims to discover more about the molecular basis of pain. He heads research projects in several areas plus two drug discovery programmes in which they seek to develop new drugs to inhibit some of the novel targets which have been discovered in their lab. Professor McNaughton is also an academic who teaches science, medical and dentistry students.

Professor McNaughton comments about his research:

"The main thrust of the work in our lab is basic science, but some of our discoveries have suggested novel “targets” for drugs effective against pain. We have started two drug discovery programmes aimed at developing novel analgesics which will inhibit these targets".

Further background:

Peter McNaughton is a Fellow of the Academy of Medical Sciences and has published extensively in Nature, Science, Neuron, EMBO Journal, Journal of Neuroscience, Journal of Physiology and elsewhere (see selected publications below). He was Professor of Pharmacology and Head of the Department of Pharmacology at the University of Cambridge from 1999-2013. He moved to the Wolfson Centre for Age-Related Research, King’s College London, on 1 Oct 2013. His current work is funded mainly by the Medical Research Council (MRC), the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust.

Tassilo Weber, co-founder of Yolife.io

Yolife is a health and wellness app, a personal coach, which promises to help people add more healthy years to their lifespans. The organisation's mission: Add 15 health years to 1 million people's lives. As well as an entrepreneur, Weber is author of Life Extension Design and works as a Design Thinking Coach & Business Model Innovation Coach.

Michael Lustgarten, Human Research Center on Aging Tufts.

Michael holds the position of Scientist II at USDA Jean Mayer Human Nutrition Research Center on Aging, Tufts University. He is author of the Microbial Burden. Lustgarten is a leading researcher on gut microbiome and serum metabolome and how it affects aging.

His research currently focuses on the role of the gut microbiome and serum metabolome on muscle mass and function in older adults. Dr. Lustgarten has been a guest lecturer at the Friedman School of Nutrition Science and Policy on topics such as the gut microbiome, serum metabolome, oxidative stress, exercise, and sarcopenia. He has contributed to 22 publications in leading peer-reviewed journals that have been cited more than 2,000 times, including 14 manuscripts as the first or last author.

Dr Marios Kyriazis, Nobel Prize for Medicine candidate 2017.

Kyriazis is a biomedical gerontologist, anti-ageing physician and theorist in extreme longevity. His research explores the interactions of humans with our technological ecosystem, and the biological consequences of these interactions. He is founder of ELPI's Foundation for Indefinite Lifespans and a Ronin Institute Scholar.

Tο ?ργο (‘The Project’)

From 22 September to 22 November 2017 Marios and his team organized a ‘never-previously-performed’ social experiment, which aimed to instil large amounts of meaningful information into the public, in order to stimulate collective brain function. The experiment took part in Larnaca, Cyprus, with the ultimate aim to reduce the impact of age-related degeneration, by upregulating brain health. Visitors from all over the world interacted with the exhibits and created images, sound, poetry, movement, and works of art.

Professor Gerald Pollack, University of Washington, Seattle.

His interests range, from biological motion and cell biology to the interaction of biological surfaces with aqueous solutions.

Pollack is a Founding Fellow of the American Institute of Medical and Biological Engineering and a Fellow of both the American Heart Association and the Biomedical Engineering Society. He is also Founding Editor-in-Chief of the journal, WATER, and has recently received an NIH Director’s Transformative R01 Award. He was the 2012 recipient of the Prigogine Medal. Moreover, he is founder of the Institute of Venture Science which exists to accelerate scientific breakthroughs.

Professor Johnjoe McFadden, University of Surrey.

McFadden became interested in the phenomenon of adaptive mutation and in 1999 wrote a paper, with Jim Al-Khalili, proposing a role for quantum mechanics in mutation. He went on to write the book, Quantum Evolution in 2000 in which he proposed a wider role for quantum mechanics in biology. His mainstream research has continued in microbial genetics, particularly in developing new systems biology approaches to infectious diseases, developing the first in silico metabolic model of the TB bacillus in 2007 and the meningococcus in 2010.

Dr. Dario Altieri, President and CEO of The Wistar Institute and Director Wistar Cancer Center

Dr. Altieri received his medical degree at the University of Milan School of Medicine, where he later earned a postgraduate specialty degree in clinical and experimental hematology. In 1987, he joined the Scripps Clinic and Research Foundation in La Jolla, California. In 1999, Dr. Altieri was named professor in the Yale University School of Medicine and 2002. He became the founding chair of the Department of Cancer Biology at the University of Massachusetts Medical School.

Altieri became Wistar Cancer Center Director and first Chief Scientific Officer in September 2010. He was appointed as President and Chief Executive Officer of Wistar in 2015.

Professor Michael Rose, University of California Irvine and Founder of Lyceum Pharmaceuticals.

Michael is an evolutionary biologist, experimental evolutionist, Omics researcher with interests in pharmaceutical R&D.

Professsor Rose's research has covered such topics as the evolution of aging, biological immortality, experimental evolution, genomics, human evolution, evolution and diet, evolution of sex, and evolutionary game theory.

Dr Jose Santiago Mejia, Founder and Chief Scientific Office Ectocrine Technologies

Researches and studies the physiological changes which are triggered by repeated exposure to the bite of laboratory-reared, pathogen-free mosquitoes, and evaluates their potential for use as biomedical tools to treat and prevent chronic non-communicable diseases. 

Transcript of this interview is found here: www.radioideaxme.com

ideaXme is a global ideas movement. It is a podcast, ambassador and mentor programme. The organisation's mission: Move the human story forward!? ideaXme Ltd.

In 2019 ideaXme will launch a global digital platform to encourage everyone, from creators to the general public to take part in the innovation, development and "forward" processes that Move the human story forward!?

ideaXme ambassadors are subject matter experts who interview thought leaders, creators, pioneers and influencers within their area of interest across the world.

Connect with us: Twitter @ideaxm Instagram: @ideaxme Facebook ideaXme

Contact us: [email protected]